Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.38 |
| ▸ | JAK3 | P52333 | 2/20 | 0.35 |
| ▸ | FPR1 | P21462 | 2/20 | 0.33 |
| ▸ | FPR2 | P25090 | 1/20 | 0.33 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3657582 | 0.94 | HRH3 (0.41) | HRH3JAK3P2RY1 | |
| Trifluoroacetic Acid SCHEMBL3650438 | 0.89 | — | — | |
| Trifluoroacetic Acid SCHEMBL3660055 | 0.85 | HRH3 (0.39) | HRH3JAK3 | |
| Trifluoroacetic Acid SCHEMBL3705581 | 0.84 | KDM4E (0.40) | — | |
| Trifluoroacetic Acid SCHEMBL3653647 | 0.84 | KMT2A (0.45) | — | |
| Trifluoroacetic Acid SCHEMBL3657860 | 0.83 | RAB9A (0.39) | — | |
| Trifluoroacetic Acid SCHEMBL3657956 | 0.82 | HRH3 (0.44) | HRH3JAK3 | |
| Trifluoroacetic Acid SCHEMBL3656237 | 0.82 | MLYCD (0.41) | — | |
| Trifluoroacetic Acid SCHEMBL3652245 | 0.82 | NPC1 (0.39) | — | |
| Trifluoroacetic Acid SCHEMBL3656228 | 0.82 | RAB9A (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2215058-A1 | SUBSTITUTED N-PHENYL-BIPYRROLIDINE UREAS AND THERAPEUTIC USE THEREOF | Sanofi-Aventis (FR) | 2010-08-11 | — | — | EP | disclosed |
| WO-2009052068-A1 | SUBSTITUTED N-PHENYL-BIPYRROLIDINE UREAS AND THERAPEUTIC USE THEREOF | SANOFI-AVENTIS (FR) | 2009-04-23 | — | — | WO | disclosed |